These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10911935)

  • 1. Ibogaine in acute opioid withdrawal. An open label case series.
    Alper KR; Lotsof HS; Frenken GM; Luciano DJ; Bastiaans J
    Ann N Y Acad Sci; 2000; 909():257-9. PubMed ID: 10911935
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acute opioid withdrawal with ibogaine.
    Alper KR; Lotsof HS; Frenken GM; Luciano DJ; Bastiaans J
    Am J Addict; 1999; 8(3):234-42. PubMed ID: 10506904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibogaine in the treatment of heroin withdrawal.
    Mash DC; Kovera CA; Pablo J; Tyndale R; Ervin FR; Kamlet JD; Hearn WL
    Alkaloids Chem Biol; 2001; 56():155-71. PubMed ID: 11705106
    [No Abstract]   [Full Text] [Related]  

  • 4. A preliminary investigation of ibogaine: case reports and recommendations for further study.
    Sheppard SG
    J Subst Abuse Treat; 1994; 11(4):379-85. PubMed ID: 7966509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes.
    Brown TK; Alper K
    Am J Drug Alcohol Abuse; 2018; 44(1):24-36. PubMed ID: 28541119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study.
    Noller GE; Frampton CM; Yazar-Klosinski B
    Am J Drug Alcohol Abuse; 2018; 44(1):37-46. PubMed ID: 28402682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ibogaine medical subculture.
    Alper KR; Lotsof HS; Kaplan CD
    J Ethnopharmacol; 2008 Jan; 115(1):9-24. PubMed ID: 18029124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic complementary medicines.
    Alper KR; Glick SD
    Br J Psychiatry; 2006 Jun; 188():587; author reply 587-8. PubMed ID: 16738355
    [No Abstract]   [Full Text] [Related]  

  • 9. Ibogaine may help drug addicts live the 'never again'.
    Bateman C
    S Afr Med J; 2006 Jul; 96(7):580, 582. PubMed ID: 16909175
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioid detoxification with delta sleep-inducing peptide: results of an open clinical trial.
    Backmund M; Meyer K; Rothenhaeusler HB; Soyka M
    J Clin Psychopharmacol; 1998 Jun; 18(3):257-8. PubMed ID: 9617990
    [No Abstract]   [Full Text] [Related]  

  • 11. Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study of five inpatients.
    Ang-Lee K; Oreskovich MR; Saxon AJ; Jaffe C; Meredith C; Ellis ML; Malte CA; Knox PC
    J Psychoactive Drugs; 2006 Dec; 38(4):505-12. PubMed ID: 17373566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.
    Popik P; Layer RT; Skolnick P
    Pharmacol Rev; 1995 Jun; 47(2):235-53. PubMed ID: 7568327
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of intravenous buprenorphine for the treatment of opioid withdrawal in medically ill hospitalized patients.
    Welsh CJ; Suman M; Cohen A; Broyles L; Bennett M; Weintraub E
    Am J Addict; 2002; 11(2):135-40. PubMed ID: 12028743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy.
    Mash DC
    Pharmacol Res; 2023 Apr; 190():106620. PubMed ID: 36907284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
    Glick SD; Maisonneuve IM; Szumlinski KK
    Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibogaine in the treatment of substance dependence.
    Brown TK
    Curr Drug Abuse Rev; 2013 Mar; 6(1):3-16. PubMed ID: 23627782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine dosing regime in the management of out-patient heroin withdrawal.
    Lintzeris N
    Drug Alcohol Rev; 2002 Mar; 21(1):39-45. PubMed ID: 12189003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy in overdose and withdrawal syndrome in heroin addicts].
    Arrizabalaga Cuesta C; Zulaica D
    Rev Enferm; 1985 Feb; 8(78):23-5. PubMed ID: 3845677
    [No Abstract]   [Full Text] [Related]  

  • 19. Ibogaine: a review.
    Alper KR
    Alkaloids Chem Biol; 2001; 56():1-38. PubMed ID: 11705103
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder - a narrative review.
    Arenson A; Campbell CI; Remler I
    J Addict Dis; 2024; 42(3):253-263. PubMed ID: 37199191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.